Bruce Voss | Lippert/Heilshorn & Associates |
Michael Nall | CEO, President & Director |
Timothy Kennedy | CFO, SVP, Operations & Corporate Secretary |
Michael Dugan | SVP, Chief Medical Officer & Medical Director |
Jason McCarthy | Maxim Group |
Sally Yanchus | Brookline Capital Markets |
Ladies and gentlemen, thank you for standing by. Welcome to the Biocept Third Quarter 2020 Financial Results Conference Call. [Operator Instructions].
As a reminder, this conference call is being recorded today, November 12, 2020. I'd now like to turn the call over to Bruce Voss.